跳至主要内容
临床试验/CTRI/2023/01/049163
CTRI/2023/01/049163尚未招募4 期

A clinical study to evaluate the effect of Shampakadi Kwatha in the management of Vatrakta w.s.r. to Hyperuricemia

Principal1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年1月25日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
Principal
入组人数
30
试验地点
1
主要终点
To evaluate the clinical efficacy of Shampakadi Kwatha in the management of Vatarakta w.s.r. to Hyperuricemia.

研究概览

简要总结

I would like to publish my trial as soon as possible . Patients will be selected from OPD/IPD of RGGPG Ayurvedic College and Hospital Paprola.

A sample of 30 patients will be registered . Patients will be divided into three groups. Patients will be assessed to evaluate the effect of Shampakadi Kwatha in the management of Vatrakta w.s.r. to Hyperuricemia.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients of either gender in the age group between 20-70 years.
  • Patients having serum uric acid level level more than 7mg/dl (male) and more than 6mg/dl (female) with or without any associated features of joint inflammation.

排除标准

  • Patient not willing for the trial.
  • Patient below age of 20 years and above 70 years of age.
  • Patient suffering from any other form of arthritis like osteoarthritis, Tubercular arthritis, Rheumatoid etc.
  • Patient suffering from chronic renal, respiratory, cardiac and hepatic disorders.
  • Patient having malignant disorder.
  • Patients who has completed participation in any other clinical trial during the past 3 months.
  • Any condition which the investigator thinks may comprise with the safety of the subject.

结局指标

主要结局

To evaluate the clinical efficacy of Shampakadi Kwatha in the management of Vatarakta w.s.r. to Hyperuricemia.

时间窗: Duration of trial : 6 weeks | Follow up : After every 2 weeks till the completion of trial | Dosage : Shampakadi kwatha – 50 ml Twice a day | Route of administration : Oral

Relief in symptoms of Vatrkata after intervention of Shampakadi kwatha

时间窗: Duration of trial : 6 weeks | Follow up : After every 2 weeks till the completion of trial | Dosage : Shampakadi kwatha – 50 ml Twice a day | Route of administration : Oral

Sandhishoola-joint pain

时间窗: Duration of trial : 6 weeks | Follow up : After every 2 weeks till the completion of trial | Dosage : Shampakadi kwatha – 50 ml Twice a day | Route of administration : Oral

Sandhishotha-Sweling of the joint

时间窗: Duration of trial : 6 weeks | Follow up : After every 2 weeks till the completion of trial | Dosage : Shampakadi kwatha – 50 ml Twice a day | Route of administration : Oral

Raga/Redness

时间窗: Duration of trial : 6 weeks | Follow up : After every 2 weeks till the completion of trial | Dosage : Shampakadi kwatha – 50 ml Twice a day | Route of administration : Oral

Twakavaivarnya/discoloration of skin

时间窗: Duration of trial : 6 weeks | Follow up : After every 2 weeks till the completion of trial | Dosage : Shampakadi kwatha – 50 ml Twice a day | Route of administration : Oral

Vidaha- Burning sensation

时间窗: Duration of trial : 6 weeks | Follow up : After every 2 weeks till the completion of trial | Dosage : Shampakadi kwatha – 50 ml Twice a day | Route of administration : Oral

Sparasashyata/tenderness

时间窗: Duration of trial : 6 weeks | Follow up : After every 2 weeks till the completion of trial | Dosage : Shampakadi kwatha – 50 ml Twice a day | Route of administration : Oral

次要结局

  • To assess the clinical safety and adverse effects of Shampakadi Kwath. Improving quality of life(At the 4weeks, 6 weeks and remain connected with telephonically to know the A.D.Rs if there is any after completion of trial)

研究者

发起方
Principal
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验